80 FR 57387 - Manufacturer of Controlled Substances Registration: AMRI Rensselaer Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 184 (September 23, 2015)

Page Range57387-57388
FR Document2015-24122

AMRI Rensselaer, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants AMRI Rensselaer, Inc. registration as a manufacturer of those controlled substances.

Federal Register, Volume 80 Issue 184 (Wednesday, September 23, 2015)
[Federal Register Volume 80, Number 184 (Wednesday, September 23, 2015)]
[Notices]
[Pages 57387-57388]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-24122]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: AMRI 
Rensselaer Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: AMRI Rensselaer, Inc. applied to be registered as a 
manufacturer of certain basic classes of controlled substances. The 
Drug Enforcement Administration (DEA) grants AMRI Rensselaer, Inc. 
registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and 
published in the Federal Register on April 22, 2015, 80 FR 22560, AMRI 
Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144 
applied to be registered as a manufacturer of certain basic classes of 
controlled substances. No comments or objections were submitted for 
this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of AMRI Rensselaer, Inc. to 
manufacture the basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.

[[Page 57388]]

    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances:

 
------------------------------------------------------------------------
           Controlled substance                       Schedule
------------------------------------------------------------------------
Marihuana (7360)..........................   I
Tetrahydrocannabinols (7370)..............  I
Amphetamine (1100)........................  II
Lisdexamfetamine (1205)...................  II
Methylphenidate (1724)....................  II
Pentobarbital (2270)......................  II
4-Anilino-N-phenethyl-4-piperidine (8333).  II
Meperidine (9230).........................  II
Fentanyl (9801)...........................  II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for use 
in product development and for distribution to its customers.
    In reference to drug code 7360 (marihuana), and 7370 (THC), the 
company plans to bulk manufacture these drugs as synthetic. No other 
activity for this drug code is authorized for this registration.

    Dated: September 16, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-24122 Filed 9-22-15; 8:45 am]
 BILLING CODE 4410-09-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of registration.
FR Citation80 FR 57387 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR